Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
22.61
-0.06 (-0.26%)
Sep 16, 2026, 3:00 PM CST

Yifeng Pharmacy Chain Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,7621,6781,5291,4121,262887.88
Depreciation & Amortization
1,5891,7241,8831,6491,4411,191
Other Amortization
233.66239.34264.93182.97145.38117.19
Loss (Gain) From Sale of Assets
-54.8-65.46-46.1-29.09-12.84-6.85
Asset Writedown & Restructuring Costs
13.7814.1218.83--1.43
Loss (Gain) From Sale of Investments
-111.71-124.75-108.13-42.37-6.87-34.37
Provision & Write-off of Bad Debts
5.610.04-2.154.5410.474.41
Other Operating Activities
404.47399.78381.92402.11382.81313.34
Change in Accounts Receivable
4.6169.26-554.45-258.28-1,013-600.7
Change in Inventory
-206.45-206.45-790.97-261.54-459.39-885.07
Change in Accounts Payable
-640.02-447.321,5931,5432,1401,177
Change in Other Net Operating Assets
243.79-21.7865.4242.423.1619.27
Operating Cash Flow
3,2423,3584,2214,6243,9202,150
Operating Cash Flow Growth
-18.31%-20.44%-8.71%17.95%82.34%-7.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-325.49-322.92-682.67-739.92-587.51-827.54
Sale of Property, Plant & Equipment
25.2924.1866.2715.789.036.52
Cash Acquisitions
-46.13-136.62-254.66-498.82-450.56-408.88
Divestitures
1.21.2----
Investment in Securities
-402.08-1,111-2,811-1,781-250.05632
Other Investing Activities
104.69118.8473.5123.915.0831.06
Investing Cash Flow
-642.52-1,426-3,609-2,980-1,274-566.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--1,814-80142.12
Long-Term Debt Repaid
--1,554-1,780-1,687-1,483-2,083
Lease Payments
-1,379-1,462-1,605-1,603-1,352-1,236
Net Debt Issued (Repaid)
-1,409-1,55433.55-1,687-1,403-1,940
Issuance of Common Stock
---7.3977.41-
Repurchase of Common Stock
-0.41-0.66-4-3.52-2.85-1.69
Common Dividends Paid
-848.14-849.31-846.54-321.88-235.02-211.89
Other Financing Activities
-85.16-76.12-103.21-87.91-91.56-30.96
Financing Cash Flow
-2,343-2,480-920.2-2,093-1,655-2,185

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
256.88-547.53-307.78-449.62991-601.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,9173,0363,5393,8843,3331,322
Free Cash Flow Growth
-15.03%-14.22%-8.89%16.53%152.02%-24.30%
Free Cash Flow Margin
11.74%12.42%14.71%17.19%16.76%8.63%
Free Cash Flow Per Share
2.372.462.873.222.751.10
Levered Free Cash Flow
2,5462,5273,2333,2033,1231,096
Unlevered Free Cash Flow
2,6282,6323,3713,3043,2261,201
Free Cash Flow After Leases
1,5381,5731,9342,2811,98186.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,5011,3631,3281,3081,053746.51
Change in Working Capital
-599.59-507.19300.791,045698.37-324.56